Ulcerative Colitis and Colon Cancer: More Controversy than Clarity

Digestive Diseases

Volumn 16, Issue 2, 1998, Pages 81-87

  Snapper, Scott B ^a,b   Syngal, Sapna ^b,c   Friedman, Lawrence S ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Carcinoma; Colon cancer; Dysplasia; Genetic markers; Inflammatory bowel disease; Surveillance, ulcerative colitis; Ulcerative colitis

Indexed keywords

COLON RESECTION; COLON TUMOR; ENDOSCOPE; HUMAN; REVIEW; RISK FACTOR; ULCERATIVE COLITIS;

COLECTOMY; COLITIS, ULCERATIVE; COLONIC NEOPLASMS; ENDOSCOPES; HUMANS; RISK FACTORS;

EID: 0032014855     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000016851     Document Type: Article

References (80)

1. Langholz E, Munkholm P, Davidsen M, Binder V: Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology 1992;103:1444-1451.
2. Gilat T, Fireman Z, Grossman A, Hacohe D, Kadhish U, Ron E, et al: Colorectal cancer in patients with ulcerative colitits. Gastroenterology 1988;94:870-877.
3. Ekbom A, Helmick C, Zack M, Adami H-O: Ulcerative colitis and colorectal cancer: a population-based study. N Engl J Med 1990;323: 1228-1233.
4. Gyde S: Screening for colorectal cancer in ulcerative colitis: Dubious benefits and high costs. Gut 1990;31:1089-1092.
5. Lennard-Jones JE, Morson BC, Ritchie JK, Williams CB. Cancer surveillance in ulcerative colitis. Experience over 15 years. Lancet 1983; ii:149-152.
6. Choi P, Kim W: Colon cancer surveillance. Gastroenterol Clin N Am 1995;24:671-687.
7. Devroede GJ, Dockerty MB, Sauer WG, Jackman RJ, Stickler GB: Cancer of the colon in patients with ulcerative colitis since childhood. Can J Surg 1972;15:369-374.
8. Brostrom O, Lofberg R, Nordenvall B, Ost A, Hellers G: The risk of colorectal cancer in ulcerative colitis. Scand J Gastroenterol 1987; 22:1193-1199.
9. Lennard-Jones JE, Melville DM, Morson BC, Ritchie JK, Williams CB: Precancer and cancer in extensive ulcerative colitis: Findings among 401 patients over 22 years. Gut 1990;31:800-806
10. Gyde S, Prior P, Allan R, Stevens A, Jewell D, Truelove S, et al: Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut 1988;29:206-217.
11. Brostrom O, Lofberg R, Ost A, Reichard H: Cancer surveillance of patients with longstanding ulcerative colitis: A clinical, endoscopic, and histologic study. Gut 1986;27:1408-1413.
12. Lashner B, Hanauer S, Silverstein M: Optimal timing of colonoscopy to screen for cancer in ulcerative colitis. Ann Intern Med 1988;108: 274-278.
13. Lashner B, Kane S, Hanauer S: Colon cancer surveillance in chronic ulcerative colitis. A historical cohort study. Am J Gastroenterol 1990; 85:1083-1087.
14. Connel WR, Lennard-Jones JE, Williams CB, Talbot IC, Price AB, Wilkinson KH: Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 1994;107:934:-944.
15. Sugita A, Sachar DB, Bodian C, Ribeiro MB, Aufses AH Jr, Greenstein AJ: Colorectal cancer in ulcerative colitis. Influence of anatomical extent and age at onset on colitis-cancer interval. Gut 1991;32:167-169.
16. Connell WR, Kamm MA, Dickson M, Balkwill AM, Ritchie JK, Lennard-Jones JE: Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease. Lancet 1994;343: 1249-1252.
17. Peppercorn MA: 6-mercaptopurine for the management of ulcerative colitis: a concept whose time has come. Am J Gastroenterol 1996;91:1689-1690.
18. Choi PM, Nugent FW, Rossi RL: Relationship between colorectal neoplasia and primary sclerosing cholangitis in ulcerative colitis. Gastroenterology 1992;103:1707-1709.
19. Broome U, Lindberg G, Lofberg R: Primary sclerosing cholangitis in ulcerative colitis: A risk factor for the development of dysplasia and DNA aneuploidy? Gastroenterology 1992; 102:1877-1880.
20. D'Haens GR, Lashner BA, Hanauer SB: Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis. Am J Gastroenterol 1993;88:1174-1178.
21. Brentnall TA, Haggitt RC, Rabinovitch PS, Kimney MB, Bronner MP, Levine DS, et al: Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1996; 110:331-338.
22. Loftus EV, Sandborn WJ, Tremaine WJ, Mahoney DW, Zinsmeister AR, Offort KP, et al: Risk of colorectal neoplasia in patients with primary scterosing cholangitis. Gastroenterology 1995;110:432-440.
23. Ahnen DJ: Controlled trials: The controls are the key. Gastroenterology 1996;110:628-629.
24. Katzka I, Brody RS, Moms E, Katz S: Assessment of colorectal cancer risk in patients with ulcerative colitis: Experience from a private practice. Gastroenterology 1983;85:22-29.
25. Pinczowski D, Ekbom A, Baron J, Yuen J, Adami HO: Risk factors for colorectal cancer in patients with ulcerative colitis: A case-control study. Gastroenterology 1994;107:117-120.
26. Lashner BA, Provencher KS, Seidner DL, Knesebeck A, Brzezinski A: The effect of folic acid supplementation on the risk of cancer or dysplasia in ulcerative colitis. Gastroenterology 1997;112:29-32.
27. Lashner BA, Heidenreich PA, Su GL, Kane SV, Hanauer SB: Effect of folate supplementation on the incidence of dysplasia and cancer in ulcerative colitis. Gastroenterology 1989;97: 255-259.
28. Riddell RH, Goldman H, Ransohoff DF, Appelman HD, Fenoglio CM, Haggitt RC, et al: Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983;14:931-968.
29. Itzkowitz SH, Greenwald B, Meltzer SJ: Colon carcinogenesis in inflammatory bowel disease. Inflamm Bowel Dis 1995;1:142-158.
30. Blackstone MO, Riddell RH, Rogers BH, Levin B: Dysplasia-associated lesion or mass (DALM) detected by colonoscopy in long-standing ulcerative colitis: An indication for colectomy. Gastroenterology 1981;80:366-374.
31. Axon AT: Cancer surveillance in ulcerative colitis: A time for reappraisal. Gut 1994;35:587-589.
32. Bernstein CN, Shanahan F, Weinstein WM: Are we telling patients the truth about surveillance colonoscopy in ulcerative colitis? Lancet 1994;343:71-74.
33. Nugent FW, Haggitt RC, Gilpin PA: Cancer surveillance in ulcerative colitis. Gastroenterology 1991;100:1241-1248.
34. Woolrich AJ, DaSilva MD, Korelitz BI: Surveillance in the routine management of ulcerative colitis: The predictive value of low-grade dysplasia. Gastroenterology 1992;103:431-438.
35. Ransohoff D, Riddell R, Levin B: Ulcerative colitis and cancer: Problems in assessing the diagnostic usefulness of mucosal dysplasia. Dis Colon Rectum 1985;28:383.
36. Kewenter J, Hulten L: The occurrence of severe epithelial dysplasia and bearing on the treatment of longstanding ulcerative colitis. Ann Surg 1982;195:209.
37. Rozen P, Baratz M, Fefer F, Gilat T: Low incidence of significant dysplasia in a successful endoscopic surveillance program of patients with ulcerative colitis. Gastroenterology 1995; 108:1361-1370
38. Rosenstock E, Farmer R, Petras R: Surveillance for colonic carcinoma for ulcerative colitis. Gastroenterology 1992;103:1611.
39. Collins R, Feldman M, Fordtran J: Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis: A critical review. N Engl J Med 1987;316:1654-1658.
40. Rosenstock E, Farmer RG, Petras R, Sivak MV Jr, Rankin GB, Sullivan BH: Surveillance for colonic carcinoma in ulcerative colitis. Gastroenterology 1985;89:1342-1346.
41. Melville DM, Jass JR, Morson BC, Pollock DJ, Richman PI, Shepherd NA, et al: Observer study of the grading of dysplasia in ulcerative colitis: Comparison with clinical outcome. Hum Pathol 1989;20:1008-1014.
42. Lashner BA, Silverstein MD, Hanauer SB: Hazard rates for dysplasia and cancer in ulcerative colitis. Results from a surveillance program. Dig Dis Sci 1989;34:1536-1541.
43. Lofberg R, Brostrom O, Karlen P, Tribukait B, Ost A: Colonoscopic surveillance in long-standing total ulcerative colitis: A 15-year follow-up study. Gastroenterology 1990;99:1021-1031.
44. Lynch DA, Lobo AJ, Sobala GM, Dixon MF, Axon AT: Failure of colonoscopic surveillance in ulcerative colitis. Gut 1993;34:1075-1080.
45. Leidenius M, Kellokumpu I, Husa A, Riihela M, Sipponen P: Dysplasia and carcinoma in longstanding ulcerative colitis: An endoscopic and histological surveillance programme. Gut 1991;32:1521-1525.
46. Rutegard J, Ahsgren L, Stenling R, Janunger KG: Ulcerative colitis. Cancer surveillance in an unselected population. Scand J Gastroenterol 1988;23:139-145.
47. Choi PM, Nugent FW, Schoetz DJ Jr, Silverman ML, Haggitt RC: Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology 1993; 105:418-424.
48. Giardiello F, Gurbuz A, Bayless T, Goodman S, Yardley J: Colorectal cancer in ulcerative colitis: Survival in patients with and without colorectal cancer symptoms. Infiamm Bowel Dis 1996;2:6-10.
49. Connell WR, Talbot IC, Harpaz N, Britto N, Wilkinson KH, Kamm MA, et al: Clinicopathological characteristics of colorectal carcinoma complicating ulcerative colitis. Gut 1994; 35:1419-1423.
50. Taylor BA, Pemberton JH, Carpenter HA, Levin KE, Schroeder KW, Welling DR, et al: Dysplasia in chronic ulcerative colitis: Implications for colonoscopic surveillance. Dis Colon Rectum 1992;35:950-956.
51. Provenzale D, Kowdley KV, Arora S, Wong JB: Prophylactic colectomy or surveillance for chronic ulcerative colitis? A decision analysis. Gastroenterology 1995;109:1188-1196.
52. Lennard-Jones J: Colitic cancer: Supervision, surveillance, or surgery? Gastroenterology 1995;109:1388-1391.
53. Ahnen D, Warren G, Greene L, Singleton J, Brown W: Search for a specific marker of mucosal dysplasia in chronic ulcerative colitis. Gastroenterology 1987;93:1346-1355.
54. Ehsanullah M, Fihpe M, Gazzard B: Mucin secretion in inflammatory bowel disease: correlation with disease activity and dysplasia. Gut 1982;23:485-489.
55. Ehsanullah M, Naunton MM, Filipe MI, Gazzard B: Sialomucins in the assessment of dysplasia and cancer-risk patients with ulcerative colitis treated with colectomy and ileo-rectal anastomosis. Histopathology 1985;9:223-235.
56. Fozard JB, Dixon MF, Axon AT, Giles GR: Lectin and mucin histochemistry as an aid to cancer surveillance in ulcerative colitis. Histopathology 1987;11:385-394.
57. Jass J, England J, Miller K: Value of mucin histochemistry in follow up surveillance of patients with long standing ulcerative colitis. J Clin Pathol 1986;39:393-398.
58. Pihl E, Peura A, Johnson W, McDermott F, Hughes E: T-antigen expression by peanut aglutinin staining relates to mucosal dysplasia in ulcerative colitis. Dis Colon Rectum 1985; 28:11-17.
59. Thor A, Itzkowitz SH, Schlom J, Kim YS, Hanaucr S: Tumor-associated glycoprotein (TAG-72) expression in ulcerative colitis. Int J Cancer 1989;43:810-815.
60. Itzkowitz S, Marshall A, Kornbluth A: Salosyl-Tn antigen: a marker of risk for colorectal neoplasia in patients with chronic ulcerative colitis. Gastroenterology 1995;109:490-497.
61. Itzkowitz S, Young E, Dubois D, Harpaz N, Bodian C, Chen A, et al: Siaosyl-Tn antigen is prevalent and precedes dysplasia in ulcerative colitis: A retrospective case-control study. Gastroenterology 1996;110:694-704.
62. Zuzuki H, Harpaz N, Tarmin Y, et al: Microsatellite instability in ulcerative colitis-associated colorectal dysplasias and cancers. Cancer Res 1994;54:4841-4844.
63. Lofberg R, Brostrom O, Karlen P, Ost A, Tribukait B: DNA aneuploidy in ulcerative colitis: Reproducibility, topographic distribution, and relation to dysplasia. Gastroenterology 1992; 102:1149-1154.
64. Lofberg R, Leijonmarck CE, Brostrom O, Hellers G, Tribukait B, Ost A: Mucosal dysplasia and DNA content in ulcerative colitis patients with ileorectal anastomosis. Follow-up study in a defined patient group. Dis Colon Rectum 1991;34:566-571.
65. Lofberg R, Tribukait B, Ost A, Brostrom O, Reichard H: Flow cytometric DNA analysis in longstanding ulcerative colitis: A method of prediction of dysplasia and carcinoma development? Gut 1987;28:1100-1106.
66. Rubin CE, Haggitt RC, Brumer GC, Brentnall TA, Stevens AC, Levine DS, et al: DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. Gastroenterology 1992;103:1611-1620.
67. Greenwald BD, Harpaz N, Yin J, Huang Y, Tong Y, Brown VL, et al: Loss of heterozygosity affecting the p53, Rb, and mcc/apc tumor suppressor gene loci in dysplastic and cancerous ulcerative colitis. Cancer Res 1992;52: 741-745.
68. Burmer GC, Rabinovitch PS, Haggitt RC, Crispin DA, Brentnall TA, Kolli VR, et al: Neoplastic progression in ulcerative colitis: Histology, DNA content, and loss of a p53 allele. Gastroenterology 1992;103:1602-1610.
69. Kern SE, Redston M, Seymour AB, Caldas C, Powell SM, Kornacki S, et al: Molecular genetic profiles of colitis-associated neoplasms. Gastroenterology 1994;107:420-428.
70. Burmer GC, Levine DS, Kulander BG, Haggitt RC, Rubin CE, Rabinovitch PS: c-Ki-ras mutations in chronic ulcerative colitis and sporadic colon carcinoma. Gastroenterology 1990;99: 416-420.
71. Bell SM, Kelly SA, Hoyle JA, Lewis FA, Taylor GR, Thompson H, et al: c-Ki-ras gene mutations in dysplasia and carcinomas complicating ulcerative colitis. Br J Cancer 1991;64:174-178.
72. Chen J, Compton C, Cheng E, Fromowitz F, Viola MV: c-Ki-ras mutations in dysplastic fields and cancers in ulcerative colitis. Gastroenterology 1992;102:1983-1987.
73. Cartwright CA, Coad CA, Egbert BM: Elevated c-Src tyrosine kinase activity in premalignant epithelia of ulcerative colitis. J Clin Invest 1994;93:509-515.
74. Brentnall TA, Crispin DA, Rabinovitch PS, Haggitt RC, Rubin CE, Stevens AC, et al: Mutations in the p53 gene: An early marker of neoplastic progression in ulcerative colitis. Gastroenterology 1994;107:369-378.
75. Taylor HW, Boyle M, Smith SC, Bustin S, Williams NS: Expression of p53 in colorectal cancer and dysplasia complicating ulcerative colitis. BrJ Surg 1993;80:442-444.
76. Yin J, Harpaz N, Tong Y, Huang Y, Laurin J, Greenwald BD, et al: p53 point mutations in dysplastic and cancerous ulcerative colitis lesions. Gastroenterology 1993;104:1633-1639.
77. Harpaz N, Peck AL, Yin J, Fiel I, Hontanosas M, Tong TR, et al. p53 protein expression in ulcerative colitis-associated colorectal dysplasia and carcinoma. Hum Pathol 1994;25:1069-1074.
78. Tarmin L, Yin J, Harpaz N, et al: APC gene mutations in ulcerative colitis associated dysplasias and cancers versus sporadic colon cancer. Cancer Res 1995;55:2035.
79. Brentnall TA, Rubin CE, Crispin DA, Stevens A, Batchelor RH, Haggitt RC, et al: A germline substitution in the human MSH2 gene is associated with high-grade dysplasia and cancer in ulcerative colitis. Gastroenterology 1995;109: 151-155.
80. Souza RF, Lei J, Yin J, Appel R, Zou T-T, Zhou C, et al: A transforming growth factor bII receptor type II mutation in ulcerative colitis-associated neoplasms. Gastroenterology 1997; 112:40-45.